HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A case of HIV encephalopathy with dementia which showed significant improvement after the combination antiretroviral therapy].

Abstract
We report a 63-year-old male with HIV encephalopathy, whose initial symptom was acutely progressing dementia. He tested positive for HIV antibody, and HIV-RNA count was 2.8 x 10(5) copy/ml. All opportunistic infections that could cause dementia were ruled out. Dementia remarkably improved after the combination antiretroviral therapy of three types of drugs, two being nucleoside analog reverse transcriptase inhibitors and one being a protease inhibitor. The combination therapy could be very effective for the treatment of HIV dementia.
AuthorsY Mizoi, M Takagi, H Hoshino, S Matsuoka, T Adachi
JournalRinsho shinkeigaku = Clinical neurology (Rinsho Shinkeigaku) Vol. 40 Issue 2 Pg. 178-80 (Feb 2000) ISSN: 0009-918X [Print] Japan
PMID10835942 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Anti-HIV Agents
  • HIV Protease Inhibitors
  • Lamivudine
  • Zidovudine
  • Indinavir
Topics
  • AIDS Dementia Complex (complications, drug therapy, etiology)
  • Anti-HIV Agents (therapeutic use)
  • Drug Therapy, Combination
  • HIV Protease Inhibitors (therapeutic use)
  • Humans
  • Indinavir (therapeutic use)
  • Lamivudine (therapeutic use)
  • Male
  • Middle Aged
  • Treatment Outcome
  • Zidovudine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: